Navigation Links
Second-Generation Female Condom is Now Available in the United States; FC2 Female Condom Will Cost 30 Percent Less than Predecessor
Date:10/1/2009

CHICAGO, Oct. 1 /PRNewswire-FirstCall/ -- The Female Health Company (FHC) (NASDAQ: FHCO) announced today that its second-generation FC2 Female Condom®, which received regulatory approval from the Food and Drug Administration in March as an HIV prevention method, is now available for purchase in the United States.

The company made the announcement in Atlanta at a meeting of the Southeastern Urban Initiative for Reproductive Health, a coalition of reproductive health advocates from Southern states that is advocating for increased federal funding for HIV prevention.

"America's HIV epidemic isn't going away. In fact, it's getting worse, and African American and Latino women are disproportionately impacted," said Dazon Dixon Diallo, Founder and President of SisterLove, a grassroots service organization that supports HIV/AIDS prevention and reproductive health programs for women in the Atlanta, Georgia region. "It's time to provide women in heavily impacted communities with expanded access to affordable women-controlled options, and the female condom becomes that choice. Women will use it if they have it."

"We're thrilled that FC2 is now available in the United States," said Mary Ann Leeper, FHC's senior strategic adviser, who will deliver a keynote address on the female condom and woman-initiated prevention at the Atlanta meeting. "We developed the female condom to provide women with access to HIV prevention that they can initiate. We know that women and men practice safer sex when they have access to more prevention methods, and we believe that access to the female condom can help millions of American women negotiate safer sex with their partners."

FC2 may be purchased from the Company's two public sector distributors: Total Access Group, Inc. '/>"/>

SOURCE Female Health Company
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
2. BiPar Announces Preclinical Data Demonstrating Anti-Tumor Activity With BSI-401, Its Second-Generation PARP Inhibitor
3. Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer
4. TAXUS OLYMPIA Registry Shows Excellent Outcomes for High-Risk Patients Treated With Second-Generation TAXUS(R) Liberte(R) Stent
5. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
6. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
7. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
8. New Data Presented on the Renessa(R) Treatment for Female Stress Urinary Incontinence
9. Female Health Company Receives Brazilian Order: Four Million FC Female Condoms
10. New Study Offers More Than a Decade of Evidence for Minimally-Invasive Surgery to Treat Female Incontinence
11. Veto of Californias Condoms in Prisons Bill: "Politics Over Public Health," Says AHF
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- EnzySurge Ltd.,(EnzySurge), a provider of innovative ... announced today that it has received clearance ... to market its new,SilverStream(TM) solution for prescription ... version of the SilverStream product. , ... of the DermaStream(R) product line.,DermaStream is a ...
(Date:12/15/2009)... -- At today,s regular meeting of the board of ... ), the board declared a regular quarterly dividend of ... holders of record at the close of business on ... ,, The Lubrizol Corporation (NYSE: LZ ... and supplies technologies that improve the quality and performance ...
(Date:12/15/2009)... Dec. 15 NxStage Medical, Inc. (Nasdaq: ... dialysis products, today announced that a group of ... be embarking on a week-long, conventional (non-dialysis) Caribbean ... The cruise, dubbed the "2010 Freedom Cruise: We,re ... Fla. on January 3, 2010 and returns on ...
Breaking Medicine Technology:EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution 2Lubrizol Declares Dividend 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4American Diversified Holdings Corporation Announces Appointment of Independent Director to the Board of the Company 62259 1American Diversified Holdings Corporation Announces Appointment of Independent Director to the Board of the Company 62259 2Advanced Health Media Honored at NJ Finest Award Ceremony 62257 1Advanced Health Media Honored at NJ Finest Award Ceremony 62257 2Rcadia COR Analyzer 28R 29 System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Art 62255 1Rcadia COR Analyzer 28R 29 System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Art 62255 2Rcadia COR Analyzer 28R 29 System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Art 62255 3
... halted tumor growth in 55% of advanced gastric cancer ... promising data, Novartis will initiate a Phase III trial ... is the second leading cause of cancer death worldwide ... AsiaEAST HANOVER, N.J., Jan. 13 Data released today ...
... Jazz Pharmaceuticals,Inc. (Nasdaq: JAZZ ) today announced ... clinical trials of JZP-6 (sodium oxybate) for the,treatment of fibromyalgia. ... second trial is a meaningful milestone,in the JZP-6 program in ... in mid-2009," said Samuel Saks, M.D., Chief Executive Officer. , ...
Other Medicine Technology:RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 2RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 3RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 4RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 5RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 6Jazz Pharmaceuticals, Inc. Completes Enrollment in Second of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia 2Jazz Pharmaceuticals, Inc. Completes Enrollment in Second of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia 3
(Date:12/16/2009)... Awarded American Podiatric Medical Association’s Seal of Acceptance , ... ... -- As shoppers continue their search for the perfect gift ... for items that are considered healthy for the environment. When ... many of today’s most stylish items are also healthy for ...
(Date:12/16/2009)... time for the Christmas rush Hallmark Cards have announced a ... the industry. With an easy to navigate website at www.hallmark.co.uk/specialoccasions ... thank you with their own words and photos and then order ... , ... Bradford, UK (PRWEB) December 16, 2009 -- ...
(Date:12/16/2009)... product or thing for your loved ones this holiday season, give ... like housekeeping, errand running, child care, and pet care through Delegate ... ... -- Residents of the Denver and Boulder metro areas have the ... and loved ones by using Delegate Source,s " Give a Gift ...
(Date:12/15/2009)... Calls For Preserving State Authority, Ban on Annual ... WASHINGTON, Dec. 15 Consumer Watchdog condemned ... those over 55 and the public option from ... group said that the Senate must still make ... to prevent ceding the entire health care system ...
(Date:12/15/2009)... coal for lying about taxes in the healthcare bill ... has earned a place under the "Naughty" column on Americans ... after being caught telling a brazen lie on the floor ... bill would not raise taxes. ,, Speaking on the ... " I have also heard it ...
Breaking Medicine News(10 mins):Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 2Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 3Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 4Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 2Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 3Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 4Health News:Give the Gift of Service This Holiday Season with Delegate Source 2Health News:Give the Gift of Service This Holiday Season with Delegate Source 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 4Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 5Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 2Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 3
... Glycoproducts International Inc., found to have committed patent and ... ... Mannatech,Incorporated (Nasdaq: MTEX ) a leading developer and ... a federal court,jury in the Northern District of Texas found ...
... Increases in Nearly All Business ... ... Board: INIS) announces financial results for,the first quarter ending March 31, 2008., ... as compared to $902,632 for the same period in 2007, an increase,of ...
... of 975 Cardiac ... ... May 12 Spectranetics,Corporation (Nasdaq: SPNC ) today announced ... effectively,assists removal of pacing and defibrillator leads. The study, "Large,Single- ...
... Study Published in Journal of Occupational and Environmental Medicine, Investigates ... ... Resource Utilization, PHILADELPHIA, May 12 High ... total,healthcare costs, according to a new study published this month ...
... 12, 2008 While it has long been known ... into any kind of tissue-specific cells, the exact mechanism ... demonstrated. Now, researchers at the Hebrew University of Jerusalem ... resolving a long-standing question as to whether the stem ...
... they drink as part of a research project aimed at ... psychologists at The University of Nottingham plan to discover whether ... of binge drinking and asking employees for a small commitment ... could change peoples binge drinking behaviour in the long term. ...
Other Medicine News:Health News:Jury Validates Key Mannatech Technology Patents Involving Its Ambrotose(R) Glyconutrient Products 2Health News:Jury Validates Key Mannatech Technology Patents Involving Its Ambrotose(R) Glyconutrient Products 3Health News:International Isotopes Inc. Announces First Quarter 2008 Financial Results 2Health News:International Isotopes Inc. Announces First Quarter 2008 Financial Results 3Health News:International Isotopes Inc. Announces First Quarter 2008 Financial Results 4Health News:Safe Options for Cardiac Lead Removal: Study Published in Heart Rhythm Journal 2Health News:Safe Options for Cardiac Lead Removal: Study Published in Heart Rhythm Journal 3Health News:New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health 2Health News:New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health 3Health News:New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health 4Health News:New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health 5Health News:How embryonic stem cells develop into tissue-specific cells demonstrated 2Health News:Think before you drink, says university research 2
... Compact high speed refrigerated floor-standing ... the popular protocols of classical 3 ... using programmed radius including for adaptors, ... 10 acceleration & 10 braking rates ...
... Low profile-general purpose refrigerated. The Centra-CL3 ... B/D Vacutainer tubes (meeting US OSHA ... with 15/50 ml Falcon/Corning conicals, large ... bottles, genomic/proteomic microplate pelleting and many ...
... R centrifuge provides versatility. This is ... selections from -10C to +25C. Automatic ... and 3-position brake switch, modular disk ... all popular size tubes and rotor ...
... Adams compact II centrifuge is ... laboratory. Attached, durable cover with ... to minimize aerosol emissions, "hold" ... temperature rise, brushless motor, maximum ...
Medicine Products: